Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Dec 13.
Published in final edited form as: Am J Crit Care. 2023 Nov 1;32(6):449–457. doi: 10.4037/ajcc2023975

Understanding and managing anxiety sensitivity during critical illness and long-term recovery

Leanne M Boehm 1,2, Claire M Bird 3, Ann Marie Warren 4,5,6, Valerie Danesh 7,8, Megan M Hosey 9,10, Joanne McPeake 11, Kelly M Potter 12, Han Su 13,14, Tammy L Eaton 15,16, Mark B Powers 17,18,19
PMCID: PMC10718181  NIHMSID: NIHMS1950527  PMID: 37907373

Abstract

Anxiety sensitivity is a fear of symptoms associated with experiencing anxiety (e.g., rapid respiration/heart rate, perspiration) also known as “Fear of Fear”. These fears are a misinterpretation of non-threatening symptoms as threatening across three domains: physical (“when my heart rate increases, I’m afraid I may have a heart attack”), social (“if people see me perspire, I fear they will negatively evaluate me”), and loss of control (“when I feel these symptoms, I fear it means I’m going crazy or will lose control and do something dangerous like disconnect my IV”). These thoughts stimulate the sympathetic nervous system resulting in stronger sensations and further catastrophic misinterpretations spiraling, at times, into a panic attack. Strategies to address anxiety sensitivity may include pharmacologic or non-pharmacologic interventions. In Intensive Care Unit (ICU) settings, anxiety sensitivity is relevant to physical, social, and loss of control spanning common monitoring and interventional procedures (e.g., oxygen therapy, repositioning, urine collection systems). Furthermore, anxiety sensitivity could be a barrier to mechanical ventilator weaning strategies when patients are uncomfortable following instructions to do awakening or breathing trials. Fortunately, anxiety sensitivity is a malleable trait with evidence-based intervention options. However, few healthcare providers are aware of this psychological construct and available treatment. This paper describes the nature of anxiety sensitivity, its potential impact on ICU care, how to assess and interpret scores from validated instruments (i.e., Anxiety Sensitivity Index), and treatment approaches across the critical care trajectory inclusive of post-ICU recovery. Implications and future directions are also discussed.

Keywords: anxiety sensitivity, critical care, intensive care unit, symptoms, treatment, critical illness recovery

Introduction

Anxiety sensitivity (AS) is the fear of experiencing anxiety-related symptoms and its associated sensations.1,2 Conceptually, AS is the intolerance or catastrophic appraisal of anxiety-related sensations that then serve to exacerbate these sensations and, in turn, leads to maladaptive escape and avoidance behaviors.2 As such, AS has shown to be an essential factor in terms of behavioral considerations and the experience of psychological distress. Once AS develops, the fears may influence health behaviors, resulting in avoidance of healthy behaviors, medication nonadherence, and engagement in maladaptive behaviors.3,4

AS is a significant predictor of psychopathology and maladaptive behaviors.2 Meta-analyses have demonstrated strong support for the relationship between anxiety-related disorders and AS, particularly posttraumatic stress disorder (PTSD), panic disorder, and suicidal ideation.5,6 AS has also been linked to chronic illness (e.g., asthma, cardiovascular disease, chronic pain), and problematic health behaviors (e.g., non-medical benzodiazepine use, tobacco use, lower exercise engagement, medication nonadherence).2,4,710 Not only do these consequences cause distress and impairment in those with AS, they also increase the burden on the healthcare system. As such, AS is associated with increased healthcare utilization and emergency room visits.11 Because AS is associated with a number of negative individual and organizational outcomes, it is considered an important psychological/behavioral condition shared across different types of health disorders (i.e., transdiagnostic factor).

AS is applicable to acute and critical illness when unpleasant sensations such as pain, shortness of breath, nausea, and thirst are experienced. While the role of AS has been examined less in individuals with critical illness, it is possible that higher AS may lead to avoidance of activities perceived to increase feared sensations and thus increase patient avoidance, affecting the delivery of critical care interventions (e.g., physical/occupational therapy, repositioning, sedative/ventilator weaning). After critical illness, this could result in disengaging with follow-up services due to fear of revisiting distressing feelings associated with the ICU admission, not participating in physical therapy due to fear of pain, or not reporting post-intensive care syndrome (PICS) symptoms (e.g., anxiety, depression, PTSD) for fear of being negatively perceived by others.

It is important for ICU providers to consider strategies to assess what may be a “true alarm” or sensations that require medical intervention versus a “false alarm” or anxiety symptoms that require a psychological intervention. For instance, patients having difficulty weaning from mechanical ventilation should undergo detailed work up for underlying medical causes (e.g., upper airway resistance, cardiac dysfunction, diaphragmatic insufficiency), prior to assessing AS for the primary cause. Moreover, fear and anxiety are a common result of ICU delirium and should be ruled out or managed prior to assessment and treatment for anxiety sensitivity, as delirium precludes proper understanding of circumstances and learning new information. This review explores the concept of AS across the trajectory of critical care, proposes a role for ICU providers in the identification and management of AS by using strategies to engage patients and care partners, and introduces future directions for critical care research.

Overview of Anxiety Sensitivity

AS is described as the fear of anxiety symptoms and beliefs about the harmfulness of anxiety symptoms.12 Just as individual responses to experiencing anxiety vary (e.g., becoming anxious with minimal provocation vs. only under the most stressful circumstances), differences in responses to AS can vary. An individual’s AS plays a key role in the maintenance of anxiety-related disorders (e.g., panic disorder, social anxiety disorder) and avoidance behaviors (e.g., substance abuse, social withdrawal, declining medical interventions). Meta-analytic reviews have established strong associations between AS and anxiety-related disorders, with particularly strong associations between AS, panic disorder, and PTSD.5,13 The domains of AS (i.e., physical, social, and cognitive concerns) are also differentially associated with anxiety-related disorders. For example, the physical concern dimension of AS is associated with panic disorder and health anxiety, while the cognitive concern dimension has been found to be greater among those with comorbid PTSD and generalized anxiety disorder.14,15

In the Zvolensky framework,2 AS serves as an intensifying factor in interpreting physiological responses (e.g., increased heart rate, tachypnea) in combination with cognitive catastrophizing (e.g., this must mean I am having a heart attack), which lead to exacerbation of anxiety and panic. Research examining the assessment and treatment of AS is expanding to advance the implications of assessing and addressing AS in the context of anxiety and high distress situations.

Identifying Anxiety Sensitivity

Anxiety sensitivity is most often measured using the validated Anxiety Sensitivity Index (ASI) and, most recently, the ASI-3.1,16 The ASI-3 is an 18-item scale measuring physical, cognitive, and social concerns individuals may have regarding their anxiety. Each item is scored from ‘very little’ to ‘very much’. Higher scores indicate greater AS, with a score ≤18 indicating very little fear of anxiety-related sensations. Below are ASI-3 statements with related thought and behavior pattern examples.

  • Physical concern: It scares me when my heart beats rapidly. Example: ‘I’m having a heart attack.’

  • Cognitive concern: It scares me when I am unable to keep my mind on a task. Example: ‘I’m afraid I will forget what I am doing and fall, so I tell the physical therapist I don’t want to stand.’

  • Social concern: I worry that other people will notice my anxiety. Example: ‘When I get scared and short of breath, I’m afraid people are going to notice and not take my medical problem seriously.’

During critical illness hospitalization, observable signs of AS may include asynchrony with the ventilator, tachypnea, tachycardia, or expressions of anxiety or agitation in the absence of physiologic explanations. Patients may also require significant staff time. Similarly, during long-term recovery from critical illness, patients with AS may need increased assessment time, extra explanation and demonstration prior to participation in physical therapy, and reassurance of safety when experiencing physical discomfort. When asked about fears during the phase after critical illness, a patient may be afraid of a heart attack or inability to breathe, people noticing or evaluating them negatively (particularly related to previously independent activities like toileting), losing control or one’s mind (especially those who experienced delirium), becoming a burden on family members, an inability to work, or dying alone.

Factors Contributing to Anxiety Sensitivity

Four concepts underpin the etiology of AS. First, genetics may contribute to AS with a heritability estimate of 45%.17,18 Second, parenting responses to childhood illness/injury may reinforce attending to and misinterpreting anxiety symptoms.19 Third, a history of unexpected panic attacks increases the likelihood of AS.20,21 Finally, stressful life events are associated with AS.18,22

Critical Illness and Anxiety Sensitivity

Anxiety and fear co-occur frequently during critical illness when patients experience a heightened volume and intensity of physiological cues and other stressors. Nearly 50% of ICU patients experience clinically significant anxiety symptoms during their ICU stay.23 Common stressors during critical illness and hospitalization can include loss of control and independence, pain, delirium, sensory deprivation, social isolation, and/or imminent death. Challenging physiological symptoms such as breathlessness, fatigue, procedural and positional pain, dizziness associated with hypotension may be viewed by patients as deadly, rather than a strange but expected component of recovery. Invasive medical procedures such as mechanical ventilation, indwelling urinary catheters, chest tubes, intravenous lines, and other tethers can be significant potential triggers for anxiety, and thus amplified with AS. Finally, several medications important in critical care (e.g., steroids, vasopressors) may be associated with increased anxiety and agitation.24 The critical care setting is a particularly stimulating environment for patients with pre-morbid AS to have these symptoms greatly exacerbated.25,266

Critical illness is a commonly fear-inducing experience. Critically ill patients are experiencing one, if not multiple, complex acute and chronic health conditions requiring close monitoring of physiological changes (e.g., organ failure, diabetes, heart disease), medication management, and diet. Patients may also associate physiological changes to past experiences requiring hospitalization, for instance, an increased heart rate right before an internal defibrillator shock. This can lead to associating heart rate changes to intense fear that another shock will occur and, thus, avoiding behaviors resulting in heart rate changes. In a study of COPD patients, after accounting for depression and anxiety, AS-physical symptoms significantly predicted increased COPD symptom exacerbations, increased emergency room visits, and hospitalizations.27

Likewise, after hospitalization, ICU survivors often struggle with anxiety and PTSD.28 Some patients report not wanting to leave the hospital for fear of getting sick again, and others describe not attending important medical care to avoid reminders of hospitalization. The physical distress, loss of control, and disorientation associated with critical illness can manifest as long-term physical and psychological trauma and vulnerability. Stressors in the form of new or worsening chronic conditions occurring during long-term ICU recovery may include physical deconditioning, cognitive impairment, depression, medication access challenges, increased healthcare utilization, and use of durable medical equipment29. Potential anxiety sensitivity triggers may include sounds (e.g., microwave timers sound like ventilator alarms), nightmares, changes in voice or swallowing due to laryngeal injuries from endotracheal intubation, or the need for mobility aids (e.g., cane, walker) to resume walking. ICU survivorship often involves psychological, cognitive, and physical difficulties as patients and care partners navigate the implications of recovery and adaptations in resuming pre-critical illness activities and routines.30,31

Traditional Approaches to Managing Anxiety Sensitivity

AS has not only been found to be an integral aspect of many anxiety and mood related disorders, but specifically a strong mediator and mechanism of change in treatment outcomes, indicating that AS should be considered as a treatment target.32,33 AS has shown to be effectively improved in tandem with treatment for a diagnosed mental health disorder, such as in cognitive behavioral therapy (CBT) for panic disorder.34,35 Due to the prevalence of AS across mental health disorders, treatments targeting AS are widely applicable to treatments for multiple mental health concerns (e.g. depression, PTSD, panic disorder).

Brief formatted treatments for individuals with high AS at risk for the development of psychopathology, have promising results.31,34,36 AS-specific treatment drawn from traditional CBT therapies includes psychoeducation, cognitive restructuring, interoceptive exposure, and situation exposure.35,37 The Unified Protocol for emotional disorders has also been used to treat AS, with interoceptive exposure highlighted as the most effective component.38 Psychoeducation targets normalizing anxiety and its related sensations, while interoceptive exposure intentionally induces anxiety-related sensations to demonstrate that experiencing these sensations will not lead to catastrophic outcomes.39 Cognitive bias modification is an intervention that prompts individuals to focus on positive information and experiences rather than negative experiences that give rise to AS. Treatment for AS in an ICU setting (e.g., psychological first aid) is different from traditional outpatient settings for formal psychiatric diagnosis (e.g., cognitive behavioral therapy for panic disorder). While traditional cognitive behavioral therapies often include 8–12 sessions, brief treatment for AS may be implemented in as little as 1 session.36 Treatments for AS have shown efficacy in reducing not only AS, but also alcohol and opioid use, anxiety and depressive symptoms, smoking cessation, and suicidal ideation.37,4043 Assessment tools like the ASI-3 can identify the primary domain of AS distress (i.e., physical, social, cognitive) to tailor treatment.

Implications for Critical Care Practice

While the assessment and management of anxiety in the trajectory of critical illness is well-established,26 the state of the science specific to AS is limited. Research is needed to inform clinical implications and interventions during and after critical illness. Patients with AS may experience increased distress when undergoing medical interventions, such as mechanical ventilation or invasive procedures, thus triggering fears of experiencing the physical symptoms of anxiety. As such, ICU providers should be aware of AS to employ clear communication, pain management, and/or relaxation techniques to mitigate distress and improve patient outcomes.

Managing Anxiety Sensitivity in the Inpatient Setting

To differentiate between AS and other medical situations, a thorough medical evaluation is typically necessary. AS can coexist with other medical conditions, and in some cases, the physical symptoms may be caused or exacerbated by anxiety. Therefore, a comprehensive evaluation considering both physical and psychological factors is often necessary to accurately manage a patient’s symptoms. However, communication barriers due to mechanical ventilation and delirium can inhibit validated assessment of AS during critical illness. Thus, management largely relies on reducing stressors through environmental modification to minimize AS triggers.

Providing basic psychoeducation about common physiological and psychological symptoms in ICU patients may provide a buffer for tempering AS. For example, “it’s normal to feel scared when you are short of breath. You are getting better, so this shortness of breath is typical and uncomfortable, but not deadly.”44 It can also help to provide education about ICU delirium, the process of resolution, and reassurance that this is not a new, permanent psychiatric condition. Helping patients identify aspects of recovery within their control may reduce anxiety and increase engagement during critical illness (e.g., physical therapy timing, type of music, communication tools).

Nurse-Led Strategies during Critical Illness

Some evidence-based strategies for reducing stressors and minimizing AS triggers include family visitation and involvement to reduce social isolation, adjusting sensory stimuli to promote a comfortable and calming environment (e.g., reduce noise levels), promoting sleep-wake balance, fostering clear and timely communication, and music therapy.45,46 When a patient is experiencing an AS crisis in need of more urgent intervention, psychological first aid can be provided (Table 1). Psychological first aid helps the patient to feel safe, connected, and supported by providing practical and emotional support.47 Psychological first aid may include assuring the patient of their safety, listening actively to concerns, using calming techniques (e.g., hand holding, breathing techniques), or providing distraction. For example, if a patient is hyperventilating, suggest they close their mouth as it is very difficult to hyperventilate with a closed mouth. If time permits, instruction to patients for paced breathing (e.g., inhale 2–3, exhale 2-3-4-5) for a 3-minute period can be employed. These activities can provide the patient with an added sense of control.

Table 1.

Anxiety Sensitivity Crisis Interventions

Activation Criteria Intervention
Hyperarousal (e.g., tachycardia, diaphoresis, restlessness)
  • Verbal reassurance of safety

  • Assessment of family/visitor involvement (presence or absence)

  • Medication management (e.g., anxiolytics, antidepressants)

  • Nurse presence to provide a calm presence

  • Assessment and changes to reduce external stimuli (e.g., lighting, visitors)

  • Use short, simple directions

  • Provide reassurance of physiological status

  • Avoid asking the patient to make decisions

Hyperventilation when not mechanically ventilated
  • Coach patient to close their mouth to inhale and exhale from their nose

  • Coach patient through paced breathing counts (inhale 3 seconds and exhale 5 seconds) for 3 minutes with instructions for the patient to self-pace and continue the exercise

  • Medication management (e.g., sedatives, anxiolytics, antidepressants)

Panic during mobilization
  • Adequate pain management

  • Coaching and reassurance during physical therapy

  • Break mobility activities into small steps (e.g., step 1 for walking is to push off with walker, now shift your weight to the front leg, next bring your back foot forward, etc.)

Family Engagement Strategies during Critical Illness

Family engagement for managing AS requires awareness of AS, its triggers, and how to recognize and manage patient symptoms. Family members can be engaged to identify root issues with the patient (e.g., tubes, lines, loss of control, previously feared triggers) and provide information on ICU treatments/equipment to facilitate a sense of control for the patient. Family members can provide important information about what helps the patient feel safe and relaxed in their day-to-day life (e.g., music preferences, relaxing touch, pleasurable activities). By extension, family may be encouraged to bring in comforting or familiar objects from home. Those who are comfortable and interested can also take an active role in patient care by helping with basic activities of daily living (e.g., grooming) and physical therapy (e.g., range of motion exercises) which may facilitate a sense of patient comfort and familiarity.48,49 Family members can also work with ICU providers and patients to set goals for ICU treatment and recovery to ensure collaborative decision making and patient empowerment.

Managing Anxiety Sensitivity during Critical Illness Recovery

Psychological first aid offered during inpatient hospitalization is not a long-term solution for AS. Patients may become fearful the breathing exercises practiced during hospitalization will not work after hospital discharge. Following robust physical assessments, to rule out any ongoing physiological issues, ICU Recovery Clinics and peer support programs could incorporate AS assessment and management for overall wellbeing. Within the multidisciplinary ICU Recovery Clinic or peer support setting, psychoeducation can be provided about the nature and causes of anxiety and panic. Psychologists and/or social workers embedded within ICU recovery programs can describe how the sympathetic nervous system is triggered causing changes to happen in the body for the purpose of protecting, keeping safe, and avoiding danger. This sympathetic response is meant to feel uncomfortable for the purpose of motivating, akin to a fire alarm, which is safe when it goes off, but alerts you to leave the building. Content areas for psychoeducation materials are described in Table 2. Given anxiety was one of the few objective constructs which did not improve in recent research which examined the effectiveness of a complex intervention for ICU survivors,50 the integration of AS assessment and management may prove incredibly important for future practice in this area.

Table 2.

Content for Anxiety Sensitivity Psychoeducational Materials

Domain Educational Content
Definition Fear of anxiety-related sensations or symptoms; a belief that these sensations are dangerous, and their presence indicates something harmful is happening
Physiology Description of sympathetic nervous system response
Causes
  • Genetics, early life experiences, exposure to trauma or stressful life events

  • Common feature of anxiety disorders (e.g., panic disorder, social anxiety disorder, generalized anxiety disorder)

Effect on daily life
  • Avoidance of situations that trigger symptoms

  • Interferes with social, occupational, academic functioning

  • Contributes to development of anxiety disorders

Treatment options Descriptions of
  • Psychological first aid

  • Cognitive behavior therapy (e.g., cognitive restructuring, exposure)

  • Psychotherapy

  • Mindfulness practices

  • Medication

Coping strategies Relaxation exercises, meditation, physical activity, social support
Lifestyle changes Avoiding caffeine, alcohol, and nicotine
Self-care Encourage hobbies, creative outlets, self-compassion
Support resources Mental health professionals, support groups, online resources

Interceptive exposure is a cognitive behavioral therapy technique for therapeutically exposing someone to bodily sensations that are associated with AS triggers in a controlled and gradual manner to reduce fear and anxiety.39 Through this exposure, the patient can better identify the difference between true and false alarms (e.g., knowing the difference between when to go to the hospital versus when the symptoms are anxiety). For each AS sensation, there are different exposures that can be simulated (e.g., hyperventilation, tachycardia), when not contraindicated, to trigger AS and perform in-the-moment cognitive modification (Table 3). The brain knows this is anxiety, but the limbic system does not. Through the interceptive exposure process, it can be acknowledged that the amygdala set off an alarm, but also acknowledged that the patient is 1) afraid of having a heart attack, 2) not having a heart attack, and 3) not dead.

Table 3.

Cognitive Modification Exemplars

Situation Sensation Thought/Stuck Point Thought Challenge Alternative Thought
Physical Therapy Lightheaded/ Short of Breath I’ll pass out, fall, and seriously injure myself.
Feels 80% likely.
How many times have you felt lightheaded or short of breath? How many times when you felt this way did you fall and seriously injure yourself?
What is the likelihood of getting hurt during physical therapy from 0 (none) to 100 (absolute)?
I’m safe. My brain is setting off an alarm. This isn’t comfortable, but also not harmful. The doctors have told me it is anxiety from hyperventilation, and this actually makes it less likely I will pass out.
My physical therapist can help me.
Walking to the bathroom Heart racing I’ll have a heart attack.
Feels 70% likely.
How many times have you noticed your heart racing? How many times when you felt this way have you had a heart attack?
What are some other reasons for your heart to be racing?
There are several reasons for my heart to be racing. The doctors said I do not have a heart condition. It is likely caused from activity, the coffee I had this morning, or anxiety. This does not mean I am having a heart attack. I will take a few deep breaths before deciding if I should call a doctor.

Research and Practice Priorities for Anxiety Sensitivity and Critical Illness

There are several AS critical care research needs across inpatient and outpatient settings, including measurement and intervention development. Population-level incidence and prevalence reports are needed to interpret the significance of AS in the critical illness trajectory. Risk factors for AS may include the types of invasive tubes and lines, sleep disruption, acute illness characteristics, and ongoing biological mechanisms such as hyperinflammation. Education and dissemination are fundamental to increasing provider awareness and assessment of AS during and after critical illness. For example, AS assessment measures could be piloted for validity and acceptability with ICU patients and survivors in partnership with qualitative description of the patient experience of AS and what helps to reduce symptoms. Protocolized intervention methods are needed to establish cause-and-effect relationships for patient-centered AS management, with corresponding feasibility studies to assess implementability, safety, and efficacy. Longitudinal studies examining interventions are warranted to evaluate short- and long-term efficacy. Addressing AS research priorities could improve quality and outcomes for individuals with AS during and after critical illness.

Conclusion

Understanding the prevalence and characteristics of AS in ICU survivors is crucial. A ‘fear of fears’ can amplify anxiety surrounding all stages of the critical illness trajectory, from ICU admission through long-term recovery. Detection and interventions in the inpatient and outpatient settings are relevant to critical care. Future research should examine the integration of AS assessment and management techniques across the critical care recovery continuum.

Funding source:

JM is funded through a Fellowship from The Healthcare Improvement Studies Institute (University of Cambridge) PD-2019-02-16. TLE acknowledges support from the VA Office of Academic Affiliations through the VA/National Clinician Scholars Program (NCSP) and the University of Michigan Medicine at University of Michigan. AMW is funded in part by the Cardiovascular Research Review Committee of the Baylor Healthcare System Foundation. MMH is supported by the Parker B. Francis Foundation and NIH/NHLBI K23HL155735. KMP is supported by the NIH/NHLBI T32 HL007820. VCD is supported by NIH/NIA R21AG080339.

Role of the sponsor:

This material is based upon work supported by the Office of Academic Affiliations, Department of Veterans Affairs. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The contents of this paper are solely the responsibility of the authors and do not necessarily represent those of the Department of Veterans Affairs or the US government.

Footnotes

Conflict of interest: All authors have disclosed they have no conflicts of interest.

Contributor Information

Leanne M Boehm, School of Nursing, Vanderbilt University, Nashville, TN, USA; Critical Illness, Brain dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA.

Claire M. Bird, Baylor University Medical Center, Dallas, TX, USA.

Ann Marie Warren, Baylor Scott & White Research Institute, Dallas, TX, USA; Baylor University Medical Center, Dallas, TX, USA; College of Medicine, Texas A&M University, Dallas, TX, USA.

Valerie Danesh, Center for Applied Health Research, Baylor Scott & White Research Institute, 3434 Live Oak Dr, Dallas, TX, 75204, USA; Baylor College of Medicine, Temple, TX, USA.

Megan M. Hosey, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Joanne McPeake, The Healthcare Improvement Studies Institute, University of Cambridge, Cambridge, UK.

Kelly M. Potter, Clinical Research, Investigation, and Systems Modeling of Acute illness (CRISMA) Center in the Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Han Su, School of Nursing, Vanderbilt University, Nashville, TN, USA; Critical Illness, Brain dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN, USA.

Tammy L Eaton, National Clinician Scholars Program (NCSP); VA HSR&D Center for the Study of Healthcare Innovation, Implementation, & Policy, University of Michigan, Ann Arbor, MI, USA; Department of Systems, Populations and Leadership, University of Michigan School of Nursing, Ann Arbor, MI, USA.

Mark B. Powers, Baylor Scott & White Research Institute, Dallas, TX, USA; Baylor University Medical Center, Dallas, TX, USA; Texas A&M University College of Medicine, Dallas, TX, USA.

References

  • 1.Reiss S, Peterson RA, Gursky DM, McNally RJ. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 1986;24(1):1–8. doi: 10.1016/0005-7967(86)90143-9 [DOI] [PubMed] [Google Scholar]
  • 2.Smits J, Otto M, Powers M, Baird S. The Clinician’s Guide to Anxiety Sensitivity Treatment and Assessment. Academic Press; 2018. [Google Scholar]
  • 3.Otto MW, Eastman A, Lo S, et al. Anxiety sensitivity and working memory capacity: Risk factors and targets for health behavior promotion. Clin Psychol Rev. Nov 2016;49:67–78. doi: 10.1016/j.cpr.2016.07.003 [DOI] [PubMed] [Google Scholar]
  • 4.Alcantara C, Edmondson D, Moise N, Oyola D, Hiti D, Kronish IM. Anxiety sensitivity and medication nonadherence in patients with uncontrolled hypertension. J Psychosom Res. Oct 2014;77(4):283–6. doi: 10.1016/j.jpsychores.2014.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Olatunji BO, Wolitzky-Taylor KB. Anxiety sensitivity and the anxiety disorders: a meta-analytic review and synthesis. Psychol Bull. Nov 2009;135(6):974–99. doi: 10.1037/a0017428 [DOI] [PubMed] [Google Scholar]
  • 6.Stanley IH, Boffa JW, Rogers ML, et al. Anxiety sensitivity and suicidal ideation/suicide risk: A meta-analysis. J Consult Clin Psychol. Nov 2018;86(11):946–960. doi: 10.1037/ccp0000342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McHugh RK, Geyer R, Karakula S, Griffin ML, Weiss RD. Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use. Am J Addict. Sep 2018;27(6):485–490. doi: 10.1111/ajad.12765 [DOI] [PubMed] [Google Scholar]
  • 8.Reuven SM, Chen TA, Zvolensky MJ, Businelle MS, Kendzor DE, Reitzel LR. Examining the moderating effect of anxiety sensitivity on past-month pain severity and heaviness of smoking among adult smokers experiencing homelessness. Addict Behav. Jan 2021;112:106610. doi: 10.1016/j.addbeh.2020.106610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Galbraith MK, DeWolfe CEJ, Bartel S, Olthuis JV, Watt MC, Stewart SH. Do anxiety sensitivity and impulsivity interact in predicting exercise involvement in emerging adult drinkers and cannabis users? Cogn Behav Ther. May 2022;51(3):243–256. doi: 10.1080/16506073.2021.1998211 [DOI] [PubMed] [Google Scholar]
  • 10.Zvolensky MJ, Smit T, Rogers AH, et al. Exploring pain experience and anxiety sensitivity among Latinx adults in a federally qualified health center. J Behav Med. Jun 2022;45(3):404–415. doi: 10.1007/s10865-022-00325-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Horenstein A, Rogers AH, Bakhshaie J, Zvolensky MJ, Heimberg RG. Examining the role of anxiety sensitivity and intolerance of uncertainty in the relationship between health anxiety and likelihood of medical care utilization. Cognitive Therapy and Research. 2019;43:55–65. [Google Scholar]
  • 12.Taylor S Anxiety sensitivity: Theory, research, and treatment of the fear of anxiety. Routledge; 2014. [Google Scholar]
  • 13.Naragon-Gainey K Meta-analysis of the relations of anxiety sensitivity to the depressive and anxiety disorders. Psychol Bull. Jan 2010;136(1):128–50. doi: 10.1037/a0018055 [DOI] [PubMed] [Google Scholar]
  • 14.Baek IC, Lee EH, Kim JH. Differences in anxiety sensitivity factors between anxiety and depressive disorders. Depress Anxiety. Oct 2019;36(10):968–974. doi: 10.1002/da.22948 [DOI] [PubMed] [Google Scholar]
  • 15.Wheaton MG, Deacon BJ, McGrath PB, Berman NC, Abramowitz JS. Dimensions of anxiety sensitivity in the anxiety disorders: evaluation of the ASI-3. J Anxiety Disord. Apr 2012;26(3):401–8. doi: 10.1016/j.janxdis.2012.01.002 [DOI] [PubMed] [Google Scholar]
  • 16.Taylor S, Zvolensky MJ, Cox BJ, et al. Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3. Psychological assessment. 2007;19(2):176. [DOI] [PubMed] [Google Scholar]
  • 17.van der Walt K, Campbell M, Stein DJ, Dalvie S. Systematic review of genome-wide association studies of anxiety disorders and neuroticism. World J Biol Psychiatry. Apr 2023;24(4):280–291. doi: 10.1080/15622975.2022.2099970 [DOI] [PubMed] [Google Scholar]
  • 18.Peel AJ, Oginni O, Assary E, et al. A multivariate genetic analysis of anxiety sensitivity, environmental sensitivity and reported life events in adolescents. J Child Psychol Psychiatry. Feb 2023;64(2):289–298. doi: 10.1111/jcpp.13725 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Casline E, Patel ZS, Timpano KR, Jensen-Doss A. Exploring the Link Between Transdiagnostic Cognitive Risk Factors, Anxiogenic Parenting Behaviors, and Child Anxiety. Child Psychiatry Hum Dev. Dec 2021;52(6):1032–1043. doi: 10.1007/s10578-020-01078-2 [DOI] [PubMed] [Google Scholar]
  • 20.Schmidt NB, Lerew DR, Joiner TE Jr. Prospective evaluation of the etiology of anxiety sensitivity: test of a scar model. Behav Res Ther. Nov 2000;38(11):1083–95. doi: 10.1016/s0005-7967(99)00138-2 [DOI] [PubMed] [Google Scholar]
  • 21.Li W, Zinbarg RE. Anxiety sensitivity and panic attacks: a 1-year longitudinal study. Behav Modif. Mar 2007;31(2):145–61. doi: 10.1177/0145445506296969 [DOI] [PubMed] [Google Scholar]
  • 22.McLaughlin KA, Hatzenbuehler ML. Stressful life events, anxiety sensitivity, and internalizing symptoms in adolescents. J Abnorm Psychol. Aug 2009;118(3):659–69. doi: 10.1037/a0016499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.May AD, Parker AM, Caldwell ES, et al. Provider-Documented Anxiety in the ICU: Prevalence, Risk Factors, and Associated Patient Outcomes. J Intensive Care Med. Dec 2021;36(12):1424–1430. doi: 10.1177/0885066620956564 [DOI] [PubMed] [Google Scholar]
  • 24.Savas M, Vinkers CH, Rosmalen JG, et al. Systemic and local corticosteroid use is associated with reduced executive cognition, and mood and anxiety disorders. Neuroendocrinology. 2020;110(3–4):282–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bienvenu OJ, Friedman LA, Colantuoni E, et al. Psychiatric symptoms after acute respiratory distress syndrome: a 5-year longitudinal study. Intensive Care Med. Jan 2018;44(1):38–47. doi: 10.1007/s00134-017-5009-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nikayin S, Rabiee A, Hashem MD, et al. Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis. Gen Hosp Psychiatry. Nov-Dec 2016;43:23–29. doi: 10.1016/j.genhosppsych.2016.08.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Witcraft SM, Dixon LJ, Leukel P, Lee AA. Anxiety sensitivity and respiratory disease outcomes among individuals with chronic obstructive pulmonary disease. Gen Hosp Psychiatry. Mar-Apr 2021;69:1–6. doi: 10.1016/j.genhosppsych.2020.12.004 [DOI] [PubMed] [Google Scholar]
  • 28.Langerud AK, Rustøen T, Småstuen MC, Kongsgaard U, Stubhaug A. Intensive care survivor-reported symptoms: a longitudinal study of survivors’ symptoms. Nurs Crit Care. Jan 2018;23(1):48–54. doi: 10.1111/nicc.12330 [DOI] [PubMed] [Google Scholar]
  • 29.Boehm LM, Danesh V, Eaton TL, et al. Multidisciplinary ICU Recovery Clinic Visits: A Qualitative Analysis of Patient-Provider Dialogues. Chest. Apr 2023;163(4):843–854. doi: 10.1016/j.chest.2022.10.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Eaton TL, Lewis A, Donovan HS, et al. Examining the needs of survivors of critical illness through the lens of palliative care: A qualitative study of survivor experiences. Intensive Crit Care Nurs. Apr 2023;75:103362. doi: 10.1016/j.iccn.2022.103362 [DOI] [PubMed] [Google Scholar]
  • 31.Hunt C, Campbell-Sills L, Chavira D, et al. Prospective relations between anxiety sensitivity and transdiagnostic anxiety following cognitive-behavioral therapy: Evidence from the Coordinated Anxiety Learning management trial. Behav Res Ther. Aug 2022;155:104119. doi: 10.1016/j.brat.2022.104119 [DOI] [PubMed] [Google Scholar]
  • 32.Asnaani A, Tyler J, McCann J, Brown L, Zang Y. Anxiety sensitivity and emotion regulation as mechanisms of successful CBT outcome for anxiety-related disorders in a naturalistic treatment setting. Journal of affective disorders. 2020;267:86–95. [DOI] [PubMed] [Google Scholar]
  • 33.Gallagher MW, Payne LA, White KS, et al. Mechanisms of change in cognitive behavioral therapy for panic disorder: The unique effects of self-efficacy and anxiety sensitivity. Behaviour research and therapy. 2013;51(11):767–777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Smits JA, Berry AC, Tart CD, Powers MB. The efficacy of cognitive-behavioral interventions for reducing anxiety sensitivity: A meta-analytic review. Behaviour research and therapy. 2008;46(9):1047–1054. [DOI] [PubMed] [Google Scholar]
  • 35.Taylor S Treating anxiety sensitivity in adults with anxiety and related disorders. The clinician’s guide to anxiety sensitivity treatment and assessment. Elsevier; 2019:55–75. [Google Scholar]
  • 36.Schmidt NB, Capron DW, Raines AM, Allan NP. Randomized clinical trial evaluating the efficacy of a brief intervention targeting anxiety sensitivity cognitive concerns. Journal of consulting and clinical psychology. 2014;82(6):1023. [DOI] [PubMed] [Google Scholar]
  • 37.Worden BL, Davis E, Genova M, Tolin DF. Development of an anxiety sensitivity (AS) intervention for high-AS individuals in substance use disorders treatment. Cognitive Therapy and Research. 2015;39:343–355. [Google Scholar]
  • 38.Boswell JF, Farchione TJ, Sauer-Zavala S, Murray HW, Fortune MR, Barlow DH. Anxiety sensitivity and interoceptive exposure: A transdiagnostic construct and change strategy. Behavior therapy. 2013;44(3):417–431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Schmidt NB, Allan NP, Knapp AA, Capron D. Targeting anxiety sensitivity as a prevention strategy. The clinician’s guide to anxiety sensitivity treatment and assessment. Elsevier; 2019:145–178. [Google Scholar]
  • 40.Paulus DJ, Brandt CP, Lemaire C, Zvolensky MJ. Trajectory of change in anxiety sensitivity in relation to anxiety, depression, and quality of life among persons living with HIV/AIDS following transdiagnostic cognitive-behavioral therapy. Cognitive behaviour therapy. 2020;49(2):149–163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zvolensky MJ, Rosenfield D, Garey L, et al. Does exercise aid smoking cessation through reductions in anxiety sensitivity and dysphoria? Health Psychology. 2018;37(7):647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Capron DW, Norr AM, Zvolensky MJ, Schmidt NB. Prospective evaluation of the effect of an anxiety sensitivity intervention on suicidality among smokers. Cognitive behaviour therapy. 2014;43(1):72–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Raines AM, Short NA, Allan NP, Oglesby ME, Schmidt NB. Examination of a brief anxiety sensitivity cognitive concerns intervention on suicidality among individuals with obsessive–compulsive symptoms. Contemporary clinical trials. 2015;45:191–195. [DOI] [PubMed] [Google Scholar]
  • 44.Spathis A, Burkin J, Moffat C, et al. Cutting through complexity: the Breathing, Thinking, Functioning clinical model is an educational tool that facilitates chronic breathlessness management. NPJ Prim Care Respir Med. May 10 2021;31(1):25. doi: 10.1038/s41533-021-00237-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Richard-Lalonde M, Gelinas C, Boitor M, et al. The Effect of Music on Pain in the Adult Intensive Care Unit: A Systematic Review of Randomized Controlled Trials. J Pain Symptom Manage. Jun 2020;59(6):1304–1319 e6. doi: 10.1016/j.jpainsymman.2019.12.359 [DOI] [PubMed] [Google Scholar]
  • 46.Luetz A, Grunow JJ, Mörgeli R, et al. Innovative ICU solutions to prevent and reduce delirium and post–intensive care unit syndrome. Thieme Medical Publishers; 2019:673–686. [DOI] [PubMed] [Google Scholar]
  • 47.Everly GS Jr, Lating JM. The Johns Hopkins guide to psychological first aid. JHU Press; 2022. [Google Scholar]
  • 48.Haines KJ, Kelly P, Fitzgerald P, Skinner EH, Iwashyna TJ. The Untapped Potential of Patient and Family Engagement in the Organization of Critical Care. Crit Care Med. May 2017;45(5):899–906. doi: 10.1097/CCM.0000000000002282 [DOI] [PubMed] [Google Scholar]
  • 49.Burns KEA, Misak C, Herridge M, et al. Patient and Family Engagement in the ICU. Untapped Opportunities and Underrecognized Challenges. Am J Respir Crit Care Med. Aug 1 2018;198(3):310–319. doi: 10.1164/rccm.201710-2032CI [DOI] [PubMed] [Google Scholar]
  • 50.Henderson P, Quasim T, Shaw M, et al. Evaluation of a health and social care programme to improve outcomes following critical illness: a multicentre study. Thorax. 2023;78(2):160–168. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES